Weill Cornell Medicine researchers have discovered that cancer-induced blood clots originate from signals in the lungs, not ...

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously ...

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously thought—according to a preclinical study by Weill Cornell Medicine, Memorial Sloan ...

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.

Cancer survivors want to see more access to screenings that they call "a game changer." It's called biomarker testing, which analyzes a patient's tissue, blood or other bodily fluids to help pinpoint ...

A new study has found that a simple blood test can accurately detect colon cancer in middle-aged and older adults. The ...

DuBois, Pennsylvania, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Lung cancer is a source of more cancer deaths in the U.S. than breast, colon and prostate cancer combined. People diagnosed with lung cancer are ...

NEW YORK – UK-based startup Oxford Cancer Analytics is using the $11 million it has raised in a Series A financing to further develop and commercialize its protein-based lung cancer screening assay.

SINGAPORE, Feb. 5, 2025 /PRNewswire/ -- Asia is the region most impacted by lung cancer, accounting for 63.1% of newly ...